Evidence map›Paper›PMID 32266645›Full record

ArticleMolecular neurobiology2020

Sub-region-Specific Optic Nerve Head Glial Activation in Glaucoma.

Kazuya Oikawa, James N Ver Hoeve, Leandro B C Teixeira, Kevin C Snyder, Julie A Kiland, N Matthew Ellinwood, Gillian J McLellan

Open access · greenAbstract read
In one paragraph

Article in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kazuya OikawaDepartment of Surgical Sciences, University of Wisconsin-Madison, Madison, WI, USA.
James N Ver HoeveDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, 1300 University Avenue, Madison, WI, 53706, USA.
Leandro B C TeixeiraMcPherson Eye Research Institute, Madison, WI, USA.
Kevin C SnyderDepartment of Surgical Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Julie A KilandDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, 1300 University Avenue, Madison, WI, 53706, USA.
N Matthew EllinwoodDepartment of Animal Science, Iowa State University, Ames, IA, USA.
Gillian J McLellanDepartment of Surgical Sciences, University of Wisconsin-Madison, Madison, WI, USA. gillian.mclellan@wisc.edu.
University of Wisconsin–Madison · USMcPherson College · USIowa State University · USSmith-Kettlewell Eye Research Institute · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT W NICKELLS · 2005 to 2026
$12.6M
Therapeutic Inhibition of Optic Nerve Head Gliosis and Fibrosis in GlaucomaR01EY027396 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI MCLELLAN, GILLIAN JANE · 2017 to 2021
$2.0M
Structural and Functional Characterization of a Novel Model for Glaucoma ResearchK08EY018609 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI MCLELLAN, GILLIAN JANE · 2008 to 2012
$860k
Spectral domain optical coherence tomography instrument for multimodal imagingS10OD018221 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI MCLELLAN, GILLIAN JANE · 2014 to 2014
$210k
Automated Tissue MicroarrayerS10OD023526 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI MATKOWSKYJ, KRISTINA A. · 2018 to 2018
$184k
BrightFocus Foundation National Glaucoma Research GrantFight for Sight Grant-in-Aid AwardIowa State University Battelle General Platform and Infrastructure AwardIowa State University the Center for Integrated Animal Genomics,NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1TR000427NCATS NIH HHS UL1 TR002373NCI NIH HHS P30 CA014520NEI NIH HHS K08 EY018609NEI NIH HHS P30 EY0016665NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY027396NEI NIH HHS S10 OD018221NIH HHS S10 OD018221NIH HHS S10 OD023526Wisconsin Alumni Research Foundation the University of Wisconsin - Madison Office of the Vice Chancellor for Research and Graduate Ed-ucation
6 · The paper itself

Abstract

Glaucoma, a multifactorial neurodegenerative disease characterized by progressive loss of retinal ganglion cells and their axons in the optic nerve, is a leading cause of irreversible vision loss. Intraocular pressure (IOP) is a risk factor for axonal damage, which initially occurs at the optic nerve head (ONH). Complex cellular and molecular mechanisms involved in the pathogenesis of glaucomatous optic neuropathy remain unclear. Here we define early molecular events in the ONH in an inherited large animal glaucoma model in which ONH structure resembles that of humans. Gene expression profiling of ONH tissues from rigorously phenotyped feline subjects with early-stage glaucoma and precisely age-matched controls was performed by RNA-sequencing (RNA-seq) analysis and complementary bioinformatic approaches applied to identify molecular processes and pathways of interest. Immunolabeling supported RNA-seq findings while providing cell-, region-, and disease stage-specific context in the ONH in situ. Transcriptomic evidence for cell proliferation and immune/inflammatory responses is identifiable in early glaucoma, soon after IOP elevation and prior to morphologically detectable axon loss, in this large animal model. In particular, proliferation of microglia and oligodendrocyte precursor cells is a prominent feature of early-stage, but not chronic, glaucoma. ONH microgliosis is a consistent hallmark in both early and chronic stages of glaucoma. Molecular pathways and cell type-specific responses strongly implicate toll-like receptor and NF-κB signaling in early glaucoma pathophysiology. The current study provides critical insights into molecular pathways, highly dependent on cell type and sub-region in the ONH even prior to irreversible axon degeneration in glaucoma.

Indexed as

AnimalsCatsCell ProliferationDisease Models, AnimalEvoked Potentials, VisualGene Expression ProfilingGlaucomaInflammationMicrogliaOptic DiskOptic NerveSignal TransductionTranscriptomeGlaucomaMicrogliaNeuroinflammationNF-κBOligodendrocyteOptic nerve headRNA-seqToll-like receptor

Identifiers

PMID32266645
PMCPMC7282894
OpenAlexW3014229599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.